| Literature DB >> 27440991 |
Claudio Vinegoni1, John M Dubach1, Paolo Fumene Feruglio2, Ralph Weissleder1.
Abstract
Small molecule therapeutic drugs must reach their intended cellular targets (pharmacokinetics) and engage them to modulate therapeutic effects (pharmacodynamics). These processes are often difficult to measure in vivo due to their complexities and occurrence within single cells. It has been particularly difficult to directly measure cellular drug target binding. Fluorescence polarization is commonly used in pharmacological screening assays to measure drug-protein or protein-protein interactions. We hypothesized that fluorescence polarization imaging could be adapted and used with fluorescently labeled drugs to measure drug target engagement in vivo. Here we summarize recent results using two photon fluorescence anisotropy microscopy. Our imaging technique offers quantitative pharmacological binding information of diverse molecular interactions at the microscopic level, differentiating between bound and unbound states. Used in combination with other recent advances in the development of novel fluorescently labeled drugs, we expect that the described imaging modality will provide a window into the distribution and efficacy of drugs in real time and in vivo at the cellular and subcellular level.Entities:
Keywords: Intravital microscopy; drug imaging; fluorescence anisotropy; fluorescence polarization; in vivo imaging; pharmacology
Year: 2016 PMID: 27440991 PMCID: PMC4946648 DOI: 10.1109/JSTQE.2015.2501384
Source DB: PubMed Journal: IEEE J Sel Top Quantum Electron ISSN: 1077-260X Impact factor: 4.544